Rituximab and donor lymphocyte infusions are an effective salvage treatment for B-cell lymphoma relapsing after reduced-intensity allogeneic stem cell transplantation

被引：0
|
作者：
Spina, F. [1 ]
Patriarca, F. [2 ]
Farina, L.
Montefusco, V.
Dodero, A.
Carniti, C.
Fanin, R. [2 ]
Corradini, P. [1 ]
机构：
[1] Univ Studi Milano, Ist Nazl Tumori, Fondaz IRCCS, Milan, Italy
[2] Azienda Ospedaliero Univ Santa Maria Misericordia, Milan, Italy
来源：
BONE MARROW TRANSPLANTATION | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S245 / S246
页数：2
相关论文
共 50 条
  • [31] An Experience of Donor Lymphocyte Infusion after Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease
    Rostami, Tahereh
    Kiumarsi, Azadeh
    PEDIATRIC REPORTS, 2020, 12 (03) : 149 - 154
  • [32] Reduced-intensity allogeneic stem cell transplantation is an effective salvage treatment for relapsed non-Hodgkin and Hodgkin's lymphomas
    Corradini, P
    Dodero, A
    Bregni, M
    Olivieri, A
    Valagussa, P
    Farina, L
    Milani, R
    Scime, R
    Rambaldi, A
    Bonifazi, F
    Patriarca, F
    Locasciulli, A
    Bacigalupo, A
    Gianni, A
    Tarella, C
    BONE MARROW TRANSPLANTATION, 2006, 37 : S47 - S47
  • [33] Salvage of multiple myeloma patients relapse after an autologous stem cell transplantation, in the era of thalidomide and reduced-intensity allogeneic stem cell transplantation
    Hardan, I
    Kneller, A
    Shimoni, A
    Berkowicz, M
    Avigdor, A
    Yeshurun, M
    Raanani, P
    Davidowich, Y
    Shemtov, N
    Ben Bassat, I
    Nagler, A
    BONE MARROW TRANSPLANTATION, 2004, 33 : S156 - S157
  • [34] Reduced-intensity allogeneic stem cell transplantation for diffuse large B-cell lymphoma: Clinical evidence of a graft-versus-lymphoma effect.
    Bishop, M. R.
    Dean, R. M.
    Steinberg, S.
    Odom, J.
    Pavletic, S. Z.
    Kasten-Sportes, C.
    Hardy, N.
    Pittaluga, S.
    Gress, R.
    Fowler, D. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 348S - 348S
  • [35] Combination of Donor Lymphocyte Infusion and Blinatumomab for B-Cell Lymphoblastic Lymphoma Relapse after Allogeneic Stem-Cell Transplantation
    Mori, Jinichi
    Shingai, Naoki
    Kobayashi, Takeshi
    Doki, Noriko
    CASE REPORTS IN ONCOLOGY, 2023, 16 (01): : 640 - 644
  • [36] Rituximab plus donor lymphocyte infusion to prevent or treat relapse for B-cell malignancies after allogeneic haematopoietic stem cell transplantation
    Cavattoni, I. M.
    Schieder, H.
    Zabelina, T.
    Bacher, U.
    Ayuk, F.
    Wolschke, C.
    Zander, A.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S213 - S214
  • [37] 5-azacitidine in combination with donor lymphocyte infusions for the treatment of patients with MDS or AML relapsing after allogeneic stem cell transplantation
    Czibere, A.
    Graef, T.
    Bruns, I.
    Zohren, F.
    Germing, U.
    Haas, R.
    Kobbe, G.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S64 - S64
  • [38] Late response to donor lymphocyte infusions in patients with chronic myeloid leukemia relapsing after allogeneic stem cell transplantation
    Gómez, M
    Urbano-Ispizua, A
    Cervantes, F
    Fernández-Avilés, F
    Rovira, M
    Carreras, E
    HAEMATOLOGICA, 2002, 87 (09) : 1003 - 1005
  • [39] Efficacy of donor lymphocyte infusions in myelodysplastic syndromes relapsing after allogeneic stem cell transplantation: Importance of karyotype.
    Selleslag, DLD
    Nollet, F
    Billiet, J
    van Droogenbroeck, J
    van Hoof, A
    van Eygen, K
    Hidajat, M
    Criel, A
    BLOOD, 2004, 104 (11) : 406A - 406A
  • [40] Bortezomib as salvage therapy for patients with multiple myeloma relapsing after a reduced intensity allogeneic stem cell transplantation
    Garcia Guinon, A.
    Sureda, A.
    Beltran, J.
    Bravo, S. J.
    Sierra, J.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S158 - S158
12345